LEADER 00000cz  a2200241n  4500 
001    D007166 
003    DNLM 
005    20230901000000.0 
008    990101 n ancnnbabn          || ana       
010    D007166 
024 8  |0https://id.nlm.nih.gov/mesh/D007166 
040    DNLM|cDNLM|dMvI 
060  0 QW 955 
072    D27.|x505.|x696.|x477.|x656 
150    Immunosuppressive Agents 
450    |wnnna|aImmunosuppressants 
450    Immunosuppressant 
450    Immunosuppressive Agent 
450    |wnnna|aAgent, Immunosuppressive 
450    |wnnna|aAgents, Immunosuppressive 
550    Antirheumatic Agents 
680    |iAgents that suppress immune function by one of several 
       mechanisms of action. Classical cytotoxic 
       immunosuppressants act by inhibiting DNA synthesis. Others
       may act through activation of T-CELLS or by inhibiting the
       activation of HELPER CELLS. While immunosuppression has 
       been brought about in the past primarily to prevent 
       rejection of transplanted organs, new applications 
       involving mediation of the effects of INTERLEUKINS and 
       other CYTOKINES are emerging. 
688    66(64)